X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Eraaya Lifespaces Ltd.
BSE CODE: 531035   |   NSE CODE: NA   |   ISIN CODE : INE432F01024   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 2049.20
97.55 ( 5% )
 
Prev Close ( Rs.)
1951.65
Open ( Rs.)
2049.20
 
High ( Rs.)
2049.20
Low ( Rs.)
2049.20
 
Volume
13807
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
21-Oct-2024 23-Oct-2024 Quarterly Results
15-Oct-2024 19-Oct-2024 Inter-alia, to consider the following businesses: 1. to appoint, Mr. Arun Batra as Director-Operations and Mr. Vivek Dave, as an Independent Director, subject to recommendation of Company s Nomination and Remuneration Committee, to enhance leadership further, align with strategic objectives, and ensure efficient integration postEbix Inc. acquisition; 2. to constitute an ESG Committee and adopt comprehensive ESG policies to ensure sustainable growth by integrating environmental, social, and governance principles into our operations, aiming to enhance transparency, drive long-term value, and support responsible business practices aligned with global standards; 3. to review business activities across verticals and locations, consider reports from TPO Bharat, an External Expert Group appointed to enhance integration efficiency, manage risks, drive improvement, optimize operations, and maximize value creation during the transition; 4. to take note of the progress of the inquiry instituted against Mr. Robin Raina, including the interim report, and other findings of High-Powered Steering Committee, Internal Auditor; 5. to decide to realign the structure of Ebix, Inc. and its global subsidiaries to ensure compliance with statutory requirements while enhancing operational effectiveness and governance; 6. to take note of the promoter family's strategic decision to designate Mr. Vikas Garg as Key Promoter, enhancing leadership visibility and stakeholder engagement through a realignment of promoter stakes;
23-Sep-2024 27-Sep-2024 Inter alia, to consider and approve:- 1. Reconstitution of Board, KMPs, Core Team. 2. Nominate director(s), Office Bearers for Ebix Inc and its global Subsidiaries. 3. Grant of Sweat Equity, ESOPs, SARs. 4. Appointment of Internal Auditors. 5. Appointment of External Expert Group. 6. Constitution of Advisory Board.
02-Sep-2024 04-Sep-2024 Inter alia, to consider and approve: 1. to take note of successful acquisition of Ebix Inc. along with all its worldwide subsidiaries, and other matters incidental thereto, connected therewith; 2. to consider, evaluate, approve, in terms of the latest developments, the proposal of further funds raising by way of issuance of equity shares, or any other equity linked instruments or securities including convertible instruments, warrants etc. subject to applicable approvals; 3.deferment/rescheduling of 58th Annual General Meeting of the company.
03-Jul-2024 09-Jul-2024 Quarterly Results
27-Jun-2024 29-Jun-2024 Inter alia, to consider the following: 1) to take status of the Bid submitted by the Company to acquire 100% equity of Ebix Inc. (?Ebix?) through a Plan of Reorganization; 2) to augment the professional governance across the organisation and to steer the Eraaya business further - as per the long-term growth plans, proposed business alliances of the Company, re-jig the core Management Team, including proposals for Mr. Robin Raina and Mr. Vikas Garg be taken on Eraaya Board of Directors and re-aligning the KMPs, other Senior Management Personnel; 3) to propel the growth further, and in order to augment the long-term resources of the Company, issuance of securities upto USD 150 Million through Private Placement, Preferential Allotment, Qualified Institutional Placement, Right Issue, Further Public Offering, in one or more trenches, or in any combination thereof; With the permission of the Chair, the Board may consider and approve any such other items, which may be considered necessary.
04-Apr-2024 11-Apr-2024 Audited Results
05-Jan-2024 13-Jan-2024 Quarterly Results
18-Oct-2023 21-Oct-2023 Increase in Authorised Capital Inter alia, to consider and approve:- 1. adoption of new business activities, in line with company?s long-term growth strategy, which could be conveniently and advantageously be combined with the existing operations of the Company and consequent alteration in Object Clause (clause III) of Memorandum of Association of the Company. 2. funds raising, as per the approved business plan and its requirements, by way of issue of equity shares/convertible instruments/other securities through preferential allotment, right issue or any other method/procedure defined under the Companies Act, 2013 and SEBI Guidelines or combination thereof, in one or more tranches; 3. increase in the Authorised Share Capital of the Company and consequent alteration of Memorandum of Association of the Company 4. To seek members? approval wherever applicable by means of passing the requisite resolution(s) for the above-said board decisions and other matters connected therewith and/or incidental thereto; and 5. to consider and approve any other item(s)
05-Oct-2023 11-Oct-2023 Quarterly Results
Page 1 of 8
PREV || NEXT